Create the Universe by Superintelligence.
What We Do
Superintelligence・Quantum Computer & Metaverse
We research and develop the superintelligence (artificial general intelligence) on the basis of a world leading technology "World System on the Basis of Bidirectional Encoder Representations from Transformers(BERT), Categorical Network(CN) and Point-Voxel Convolutional Neural Network(PVCNN)." While general artificial intelligence is "specialized artificial intelligence" limited to one function, our vision's artificial intelligence is "artificial general intelligence(AGI)" that realizes various functions in a single AI and can perform all human actions significantly more highly than humans. We will develop and provide this on a huge platform with a quantum computer as the backend and a metaverse as the frontend.
Whitepapers
Case 1:
Categorical AI (Technical Report)
Case 2:
Case 3:
A Novel Approach to Generate Voxel Imagery from Natural Language Using a Fusion of DALL·E and PVCNN
Case 4:
PVCNN: A Novel Digital Twin Technology for Voxel-Based Modeling and Simulation
Case 5:
Case 6:
Quantum Neuromorphic Nano-Network: A Revolutionary Paradigm for Whole-Brain Emulation
Bio・Chemistry・Pharmaceuticals/Life science
As a technology conglomerate, we conduct R&D in several areas: bio, chemistry, pharmaceuticals・life sciences on the basis of a world leading technology "World System on the Basis of Bidirectional Encoder Representations from Transformers(BERT), Categorical Network(CN) and Point-Voxel Convolutional Neural Network(PVCNN)." AGI based on category theory unifies large-scale language models based on Transformer, and ML models informed of chemistry and physics. In addition, "new coupling" can be achieved by linking different knowledge domains with functors. This will lead to the invention of new drugs and the discovery of new chemical substances.
Whitepapers
Case 1:
Case 2:
Case 3:
Case 4:
Case 5:
Case 6:
Investment Banking
We will apply AGI to M&A-related operations, capital procurement-related operations, and proprietary investment-related operations and automate strategy formulation, due diligence, business planning, and asset portfolio optimization to achieve higher performance at lower cost and over a shorter time span than other bulge bracket firms. In addition, clients can receive not only traditional support in the investment current industry, such as M&A support and capital raising support, but also cutting-edge technical support, such as value enhancement based on technological development using AGI.
Whitepapers
Case 1:
Case 2:
Case 3:
CryptoFAPOS: A Novel Factor-Based Framework for
Cryptocurrency Investment and Risk Management
Scientific Research
We make AGI perform scientific research. AGI based on category theory can think in a unified way about all areas of science and create innovative knowledge. Also, it can automate many processes of scientific research, from the proposals of theories and experiments with computer simulations to the writing and peer review of papers.
Whitepapers
Case 1:
Case 2:
Case 3:
New York General Group Presents New Vision at the United Nations 2023 United Nations Climate Change Conference (COP28)
Our Reports
Artificial General Intelligence (AGI), capable of
understanding, learning, and performing any intellectual task that a
human can, has the potential to transform various industries,
including biotechnology, chemicals, pharmaceutical/life sciences,
and technology.
Artificial General Intelligence (AGI), often depicted as the apex of cognitive computing, refers to a type of artificial intelligence that encompasses the capacity to understand, learn, apply knowledge, and improvise in ways that are indistinguishably akin to human cognitive functions. The inception of AGI marks a paradigmatic shift in computational methodologies, calling for an urgent need to reevaluate existing corporate strategies.
Main Articles
by New York General Group
Quantum Mechanics Informed AGI
for Semiconductor Industry
Factory Full Automation with Physics Informed Metaverse
Quantum Mechanics Informed AGI
for Biotechnology Industry
Quantum Mechanics Informed AGI
for Biotechnology Industry
About Us
Today, the world is moving at ultra-high speed: rapid urbanization, climate change and resource scarcity, demographic shifts, shifts in global economic power, and technological advances. In the shifting world, New York General Group was founded in the U.S. in 2021. We are a global conglomerate based on high technology: "World System on the Basis of Bidirectional Encoder Representations from Transformers(BERT), Categorical Network(CN) and Point-Voxel Convolutional Neural Network(PVCNN)." We plan to enlarge in 6 areas: AI・quantum computer & metaverse, bio, chemistry, pharmaceuticals・life science, investment banking and scientific research・think tank. Below are three figures regarding us.
25
>$10B
New York General Group has over $10 billion† technology in bio, chemistry and pharmaceutical・
life sciences.
New York General Group has $527.1 billion† AI technology assets. (2023)
$527.1B
† It was evaluated by our proprietary AI IBIS (Investment Banking Informed Superintelligence).
2111→2025
Sandberg & Bostrom of Oxford University predict that Artificial General Intelligence at the molecular level will not be realized until 2111 or later. However, our own innovative technology "World System" will accelerate this and make it possible in 2025.
Contact Us
New York General Group